SLG
37
6
URBN
67
3
CCL
68
6
CFG
36
12
ICE
53
5
M
40
3
MRK
25
2
CNP
59
17
TXN
29
4
GWW
50
9
AAL
56
5
BXP
39
5
WFC
58
8
ETN
64
4
V
70
14
PYPL
49
4
WMB
58
3
CMS
57
2
PHM
44
4
AMP
43
2
SLG
37
6
URBN
67
3
CCL
68
6
CFG
36
12
ICE
53
5
M
40
3
MRK
25
2
CNP
59
17
TXN
29
4
GWW
50
9
AAL
56
5
BXP
39
5
WFC
58
8
ETN
64
4
V
70
14
PYPL
49
4
WMB
58
3
CMS
57
2
PHM
44
4
AMP
43
2
Financhill
Back

Universe Pharmaceuticals 10K Form

Sell
11

UPC
Universe Pharmaceuticals

Last Price:
$0.64
Seasonality Move:
-27.01%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive UPC News And Ratings

See the #1 stock for the next 7 days that we like better than UPC

UPC Financial Statistics

Sales & Book Value

Annual Sales: $32.3M
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $110.01
Price / Book: 0.04

Profitability

EPS (TTM): -76.35000
Net Income (TTM): $-18.5M
Gross Margin: $10.3M
Return on Equity: -49.07%
Return on Assets: -32.15%

Universe Pharmaceuticals Earnings Forecast

Key Universe Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 6 years for UPC is 31.93%.
  • The Selling, General & Administrative Expenses for UPC have been equal to 27.86% of Gross Profit Margin.
  • The Research & Development expenses have been 15.04% of Revenue.
  • The Interest Expense is -2.54% of Operating Income.
  • The Net Earning history of UPC is -19.08% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 3 years.

Universe Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: UPC
Website: universe-pharmacy.com

Debt

Debt-to-Equity Ratio: 0.24
Current Ratio: 1.63
Quick Ratio: 1.25

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

UPC Technical Analysis vs Fundamental Analysis

Sell
11
Universe Pharmaceuticals (UPC) is a Sell

Is Universe Pharmaceuticals a Buy or a Sell?